Calciferol cholecalciferol

Pro Research Analysisby

Searched over 200M research papers for "calciferol cholecalciferol"

Analyzed relevant papers

The Efficacy of Cholecalciferol (Vitamin D3) in Various Health Conditions

Cholecalciferol in Hemodialysis Patients

Cholecalciferol supplementation has been studied extensively in hemodialysis patients, who often suffer from vitamin D deficiency. A randomized controlled trial demonstrated that cholecalciferol significantly increased serum levels of 25-hydroxyvitamin D [25(OH)D] and 1,25-dihydroxyvitamin D without causing hypercalcemia or hyperphosphatemia. However, no significant improvements were observed in muscle strength, functional capacity, pulse wave velocity (PWV), or health-related quality of life (HRQOL) . Another study found that cholecalciferol effectively increased serum 25(OH)D levels and fetuin-A, a marker associated with vascular health, but did not significantly affect other markers like fibroblast growth factor (FGF-23) or osteoprotegerin (OPG) . These findings suggest that while cholecalciferol can correct vitamin D deficiency in hemodialysis patients, its impact on broader health outcomes may be limited.

Cholecalciferol vs. Ergocalciferol

Comparative studies have shown that cholecalciferol (vitamin D3) is more potent than ergocalciferol (vitamin D2) in increasing serum 25(OH)D levels. In elderly patients, a single large dose of cholecalciferol resulted in significantly higher serum 25(OH)D levels compared to ergocalciferol, regardless of the administration route (oral or intramuscular) . Similarly, in hip fracture patients, cholecalciferol supplementation led to a greater increase in serum 25(OH)D levels than ergocalciferol, although both forms had similar effects on parathyroid hormone (PTH) levels . These studies highlight the superior efficacy of cholecalciferol in improving vitamin D status.

Cholecalciferol in Chronic Kidney Disease (CKD)

In patients with CKD stages 3-4, high doses of cholecalciferol were found to stabilize PTH levels, preventing the progression of secondary hyperparathyroidism (SHPT) without causing hypercalcemia or other adverse effects . This suggests that cholecalciferol can be a safe and effective option for managing SHPT in CKD patients.

Cholecalciferol vs. Calcifediol

While cholecalciferol is effective in raising serum 25(OH)D levels, studies indicate that calcifediol (25-hydroxyvitamin D3) may be even more potent. In postmenopausal women with vitamin D deficiency, calcifediol supplementation resulted in significantly higher serum 25(OH)D levels compared to cholecalciferol . Another study in older adults with hypovitaminosis D found that calcifediol led to higher circulating 25(OH)D levels than cholecalciferol after three months of treatment . Despite these findings, cholecalciferol remains the preferred form of vitamin D for supplementation due to its well-established efficacy and safety profile .

Conclusion

Cholecalciferol is a highly effective form of vitamin D supplementation, particularly in increasing serum 25(OH)D levels. It is more potent than ergocalciferol and has been shown to be safe and effective in various populations, including hemodialysis patients and those with CKD. While calcifediol may offer faster and higher increases in serum 25(OH)D levels, cholecalciferol remains the preferred choice for most clinical guidelines due to its extensive evidence base and flexible dosing options.

Sources and full results

Most relevant research papers on this topic

Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients.

Cholecalciferol supplementation improves vitamin D levels in hemodialysis patients without increasing calcium or phosphorus levels, but does not affect muscle strength, functional capacity, or quality of life.

RCT

2013·

97citations

·N. Hewitt et al.

Clinical journal of the American Society of Nephrology : CJASN·

DOI

Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly.

Cholecalciferol is nearly twice as potent as ergocalciferol in increasing serum 25(OH)D levels and modulating serum PTH in elderly female patients with vitamin D deficiency.

RCTRigorous Journal

2008·

335citations

·E. Romagnoli et al.

The Journal of clinical endocrinology and metabolism·

DOI

Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial

Calcifediol is more effective, faster, and more potent than cholecalciferol in raising serum vitamin D levels in postmenopausal women, offering a valuable option for vitamin D deficiency treatment.

RCTLarge Human TrialVery Rigorous Journal

2021·

44citations

·J. Pérez-Castrillón et al.

Journal of Bone and Mineral Research·

DOI

High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3–4: results of a 12-week double-blind, randomized, controlled study

High doses of cholecalciferol effectively halt the progression of secondary hyperparathyroidism in patients with chronic kidney disease Stages 3-4, without causing hypercalcaemia or other side effects.

RCT

2017·

47citations

·Per-Anton Westerberg et al.

Nephrology Dialysis Transplantation·

DOI

A Randomized, Open-Label Study to Assess Efficacy of Weekly Assumption of Cholecalciferol versus Calcifediol in Older Patients with Hypovitaminosis D

Calcifediol supplementation is more effective than cholecalciferol supplementation in reaching optimal circulating vitamin D3 levels in older patients with hypovitaminosis D.

RCTRigorous Journal

2021·

8citations

·C. Okoye et al.

Geriatrics·

DOI

The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study.

Cholecalciferol effectively and tolerably improves vitamin D deficiency and vascular calcification in hemodialysis patients without causing adverse effects.

RCT

2020·

20citations

·Mona Alshahawey et al.

Nutrition, metabolism, and cardiovascular diseases : NMCD·

DOI

Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency

Cholecalciferol is the preferred form of vitamin D supplementation for musculoskeletal diseases, with calcifediol reserved for patients with liver failure or severe intestinal malabsorption syndromes.

Literature ReviewVery Rigorous Journal

2020·

67citations

·M. Henríquez et al.

Nutrients·

DOI

Vitamin D supplementation: cholecalciferol, calcifediol, and calcitriol

Cholecalciferol is the only form of vitamin D that should be considered for fortification and supplementation, as it is more stable, potent, and resistant to breakdown in cooking and baking compared to ergocalciferol.

2020·

94citations

·R. Vieth

European Journal of Clinical Nutrition·

DOI

Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study.

Cholecalciferol is effective and safe for increasing vitamin D levels in haemodialysis patients without negatively affecting calcium, phosphorus, PTH levels, or vascular calcifications.

RCT

2013·

81citations

·P. Delanaye et al.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·

DOI

Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.

Cholecalciferol supplementation is more effective in increasing serum 25-hydroxyvitamin D levels than ergocalciferol in vitamin D-insufficient hip fracture patients, but their impact on PTH levels remains unclear.

RCT

2009·

104citations

·P. Glendenning et al.

Bone·

DOI

Try another search

vitamin a vegetables

probiotics for constipation

vitamin c linus pauling

3d black hole simulation

vitamin d deficiency guidelines

vitamin d deficiency specialist